Last €9.55 EUR
Change Today -0.05 / -0.52%
Volume 16.9K
As of 11:38 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

C/ Julián Camarillo, 35

Madrid, 28037

Spain

Phone: 34 91 375 62 30

Fax: 34 91 304 78 81

Laboratorios Farmacéuticos ROVI, S.A. engages in the research, development, in licensing, manufacturing, and marketing of small molecule and specialty biologic drugs in Spain and internationally. Its principal product includes Bemiparin, a low molecular weight heparin. The company’s prescription products comprise Hibor to prevent thromboembolic disease; Osseor to treat post-menopausal osteoporosis; Hepadren for the prevention of clotting in the extracorporeal circuit; Pneumovax-23, a vaccine for immunization against pneumococcal illness; Glufan for relieving symptoms of degenerative osteoarthritis; and Corlentor for treating chronic stable angina pectoris. Its prescription products also include Exxiv for relieving the symptoms of osteoarthritis, rheumatoid arthritis, ankylosing spondylarthritis, and acute gouty arthritis; Calcio y Vitamina D3 ROVI to treat osteoporosis; Bertanel to treat adults active rheumatoid, juvenile idiopatic, and psoriatic arthritis; Vytorin for patients with primary hypercholesterolaemia or mixed hyperlipidaemia; Absorcol for patients with hypercholesterolaemia and phytosterolaemia; and Thymanax for treating depressive episodes in adults. In addition, the company offers diagnostic products, such as SonoVue contrast medium for use with ultrasound imaging; and Iopamiro and Iomeron contrast media for diagnosis by computed tomography; and Multihance And Prohance for use in diagnostic magnetic resonance imaging, as well as OTC products comprising Perspirex to control sweating from the armpits; Enerzone, a protein product; Dentimelo to repair oral mucosal lesions and gums; and ColdPack cold and hot bag for reliving pain. Further, it distributes products licensed from other laboratories. The company was founded in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmacéuticos ROVI, S.A. is a subsidiary of Inversiones Clidia, S.L.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ROVI:SM €9.55 EUR -0.05

ROVI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ROVI.
View Industry Companies
 

Industry Analysis

ROVI

Industry Average

Valuation ROVI Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 15.1x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORIOS FARMACEUTICOS R, please visit www.rovi.es. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.